SAGE Therapeutics Inc
F:SG7
SAGE Therapeutics Inc
F:SG7
Price:
7.58
EUR
Market Closed
Market Cap:
€456.2m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
S
|
SAGE Therapeutics Inc
F:SG7
|
US |
|
G
|
GBS Software AG
XMUN:INW
|
DE |
|
M
|
Millbank Mining Corp
XTSX:MILL
|
CA |
|
R
|
RT Minerals Corp
OTC:RTMFF
|
CA |
|
Himatsingka Seide Ltd
BSE:514043
|
IN |
|
P
|
Pure Storage Inc
F:6PU
|
US |
|
G
|
Goliath Resources Ltd
OTC:GOTRF
|
CA |
|
D
|
Douglas Dynamics Inc
F:5D4
|
US |
|
Morgan Sindall Group PLC
F:0KN
|
UK |
Price Target
Loading...
Revenue
Loading...
Gross Profit
Loading...
Operating Income
Loading...
Pre-Tax Income
Loading...
Net Income
Loading...
Wall St Price Targets
SG7 Price Targets Summary
SAGE Therapeutics Inc
SAGE Therapeutics Inc
There are no price targets for SG7.
Lowest Forecast
Price Target
Not Available
Average Forecast
Price Target
Not Available
Highest Forecast
Price Target
Not Available
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is SG7's stock price target?
Not Available
SG7 does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for SAGE Therapeutics Inc?
Projected CAGR
57%
57%
The compound annual growth rate for Revenue over the next 3 years is 57%.
